C-reactive protein in patients with chronic stable angina: Differences in baseline serum concentration between women and men

European Heart Journal

Volumn 21, Issue 19, 2000, Pages 1598-1606

  Garcia Moll, X ^a   Zouridakis, E ^a   Cole, D ^a   Kaski, Juan Carlos ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

C reactive protein in women; Inflammation; Stable angina

Indexed keywords

C REACTIVE PROTEIN; HORMONE;

ADULT; AGED; ANGINA PECTORIS; ARTICLE; CARDIOVASCULAR RISK; FEMALE; FOLLOW UP; HORMONE SUBSTITUTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEX DIFFERENCE;

ANGINA PECTORIS; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CHRONIC DISEASE; CORONARY ANGIOGRAPHY; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SEX CHARACTERISTICS;

EID: 0033794892     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1053/euhj.2000.2128     Document Type: Article

References (46)

1. Atherosclerosis - An inflammatory disease
2. Fibrinogen as a cardiovascular risk factor: Inter-relationship with infections and inflammation
3. Risk factors for coronary heart disease and acute-phase proteins. A population-based study
4. Elevation of C-reactive protein in 'active' coronary artery disease
5. Measurement of plasma C-reactive protein concentration in myocardial ischemia and infarction
6. Serum C-reactive protein and infarct size in myocardial infarct patients with a closed versus an open infarct-related coronary artery after thrombolytic therapy
7. The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina
8. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris
9. Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study
10. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
11. Production of C-reactive protein and risk of coronary events in stable and unstable patients
12. Determinants of plasma fibrinogen: Relation to body weight, waist-to-hip ratio, smoking, alcohol, age, and sex. Results from the Second MONICA Augsburg Survey, 1989-1990
13. Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women
14. Relationship of C-reactive protein to risk of cardiovascular disease in the elderly. Results from the Cardiovascular Health Study and the Rural Health Promotion Study
15. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women
16. Increased C-reactive protein levels during short-term hormone replacement therapy in healthy postmenopausal women
17. Hormone replacement therapy and increased plasma concentration of C-reactive protein
18. Effect of postmenopausal hormones on inflammation-sensitive proteins: The Postmenopausal Estrogen/Proestin Interventions (PEPI) study
19. Hormone replacement therapy and sensitive C-reactive protein concentrations in women with type-2 diabetes
20. Rapid angiographic progression of coronary artery disease in patients with angina pectoris. The role of complex stenosis morphology
21. Fibrinogen, cigarrette smoking, and risk of cardiovascular disease: Insights from the Framingham Study
22. Fibrinogen and risk of cardiovascular disease
23. Menopausal status and haemostatic variables
24. Association between fibrinogen and other risk factors for cardiovascular disease in men and women. Results from the Goteborg MONICA survey 1985
25. Serum levels of t-PA, free PAI-1 and a complex of t-PA with PAI-1 in human males and females at various ages
26. Epidemiological study on factor VII, factor VIII and fibrinogen in an industrial population: I. Baseline data on the relation to age, gender, body-weight, smoking, alcohol, pill-using, and menopause
27. Associations of factor VII and von Willebrand factor with age, race, sex, and risk factors for atherosclerosis. The Atherosclerosis Risk in Communities (ARIC) Study
28. Antithrombin III and procoagulant activity: Sex differences and effects of the menopause
29. Protein C activity in healthy volunteers - Influence of age, sex, smoking and oral contraceptives
30. Influence of age, gender and lipoprotein metabolite parameters on the activity of plasminogen activator inhibitor and the fibrinogen concentration
31. Haemostasis factors in angina pectoris; Relation to gender, age and acute-phase reaction. Results of the ECAT Angina Pectoris Study Group
32. Postmenopausal estrogen and prevention bias
33. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women
34. Long-term effects of hormone replacement therapy on symptoms of angina pectoris, quality of life and compliance in women with coronary artery disease
35. Hormone replacement therapy and circulating ICAM-1 in postmenopausal women - A randomised controlled trial
36. Transdermal estrogen replacement therapy: Beneficial effects on hemostatic risk factors for cardiovascular disease
37. Efects of hormone-replacement therapy on fibrinolysis in postmenopausal women
38. The effects of oestrogen replacement therapy on haemostatic variables in postmenopausal women with non-insulin-dependent diabetes mellitus
39. IFNB2/BSF2/IL6 is the monocyte-derived HSF that regulates receptor-specific acute phase gene regulation in hepatocytes
40. Repression of the Interleukin-6 promoter by estrogen receptor is mediated by NF-κB and C/EBPβ
41. Estrogen decreases TNF gene expression by blocking JNK activity and the resulting production of c-Jun and JunD
42. Correlation of interleukin-6 serum levels with bone density in postmenopausal women
43. Elevated plasma levels of interleukin-6 in postmenopausal women do not correlate with bone density
44. Estrogen loss upregulates hematopoiesis in the mouse: A mediating role of IL-6
45. The effect of medical and surgical treatment on subsequent sudden cardiac death in patients with coronary artery disease: A report from the Coronary Artery Surgery Study